Insider · CIK 0001827639
Mastrocola Lauren
officer
Files at PRAX (Praxis Precision Medicines, Inc.). First filing Nov 15, 2024, latest Nov 15, 2024.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $424k sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Side | Company | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 34Weak | sell 2 | PRAX Praxis Precision Medicines, Inc. | $424k | 5,188 | -48% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 14, 2024 | PRAX Praxis Precision Medicines, Inc. | AGrant or award Common Stock | +294 | $37.40 | $11k | 5,907 | Nov 19, 2024 |
| Nov 14, 2024 | PRAX Praxis Precision Medicines, Inc. | MOption exercise Common Stock | +4,374 | $56.94 | $249k | 10,801 | Nov 15, 2024 |
| Nov 14, 2024 | PRAX Praxis Precision Medicines, Inc. | SOpen-market sale Common Stock | -5,188 | $81.78 | $424k | 5,613 | Nov 15, 2024 |
| Nov 14, 2024 | PRAX Praxis Precision Medicines, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -4,374 | $0.00 | $0 | 16,626 | Nov 15, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.